prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma
Telephone:
E-mail:
m.j.postma rug.nl

Research

  1. 2013
  2. Sinclair, M., Lis, Y., Van Engen, A., Van Ganse, E., Autier, P., Daumer, M., Ehrenstein, V., Qizilbash, N., Méndez, I., Engel, P., Bergman, U., Fusco, D., Pasterk, M., Postma, M. J., Smulders, M., Van Staa, T., Pariente, A., Ruether, E., Toussi, M., ... Prieto, L. (2013). Introducing the encepp working group (WG) on health technology assessment (HTA): Enhancing the generation of additional evidence for HTA processes. Value in Health, 16(7), A491. https://doi.org/10.1016/j.jval.2013.08.977
  3. Xiridou, M., Vriend, H. J., Lugner, A. K., Wallinga, J., Fennema, J. S., Prins, J. M., Geerlings, S. E., Rijnders, B. J. A., Prins, M., de Vries, H. J. C., Postma, M. J., van Veen, M. G., Schim van der Loeff, M. F., & van der Sande, M. A. B. (2013). Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men. BMC Infectious Diseases, 13(1), [436]. https://doi.org/10.1186/1471-2334-13-436
  4. Vriend, H. J., Lugnér, A. K., Xiridou, M., Van Der Loeff, M. F. S., Prins, M., De Vries, H. J. C., Geerlings, S. E., Prins, J. M., Rijnders, B. J. A., Van Veen, M. G., Fennema, J. S. A., Postma, M. J., & Van Der Sande, M. A. B. (2013). Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective. Aids, 27(14), 2281-2290. https://doi.org/10.1097/QAD.0b013e32836281ee
  5. Urbanus, A. T., van Keep, M., Matser, A. A., Rozenbaum, M. H., Weegink, C. J., van den Hoek, A., Prins, M., & Postma, M. J. (2013). Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? PLoS ONE, 8(8), [e70319]. https://doi.org/10.1371/journal.pone.0070319
  6. Vegter, S., van Boven, J., Hiddink, E. G., & Postma, M. (2013). Economische uitkomsten. In JJ. de Gier, ML. Bouvy, ACG. Egberts, & PAGM. de Smet (Eds.), Handboek farmaceutische patiëntenzorg: achtergronden en praktijk (Vol. Hoofdstuk 21, pp. 275-282)
  7. van Hulst, M., & Postma, M. (2013). Health economics of technologies in blood transfusion within the context of general HTAs. In C. T. Smit Sibinga (Ed.), Quality management in transfusion medicine (pp. 385-411). [Chapter XII] Nova Science Publishers.
  8. Postma, M., Boersma, C., Vegter, S., VanDijck, D., & Annemans, L. (2013). Pharmacoeconomics of pharmacogenetics within the context of general health technology assessments. In Y-W. F. Lam, & LH. Cavallari (Eds.), Pharmacoeconomics (Vol. Chapter 12, pp. 429-450)
  9. 2012
Previous 1...4 5 6 7 8 9 10 11 ...15 Next

ID: 193217